On June 4, Oppenheimer raised its price target on CME Group Inc. (NASDAQ:CME) to $300 from $282, maintaining an Outperform rating, as recent trading activity points to heightened market engagement ...

Oppenheimer raised the firm’s price target on CME Group (CME) to $258 from $245 and keeps an Outperform rating on the shares. The firm says CME set another record quarter, with Q3 adjusted EPS ...

On Thursday, Oppenheimer maintained its Outperform rating on CME Group (NASDAQ: CME) shares and increased the price target to $258 from the previous $245.

The latest price target for CME Group (NASDAQ:CME) was reported by Oppenheimer on June 4, 2025. The analyst firm set a price target for $300.00 expecting CME to rise to within 12 months (a ...

CME Group (NASDAQ:CME – Free Report) had its price target hoisted by Oppenheimer from $245.00 to $258.00 in a research note released on Thursday morning, Benzinga reports.The firm currently has ...

Fintel reports that on July 27, 2023, Oppenheimer reiterated coverage of CME Group Inc - (NASDAQ:CME) with a Outperform recommendation. As of July 6, 2023, the average one-year price target for ...

In a report released today, Owen Lau from Oppenheimer maintained a Buy rating on CME Group (CME – Research Report), with a price target of $228.00. The company’s shares closed yesterday at ...

Oppenheimer lifts CME Group stock price target on strong quarter ...